The aim of the study was to evaluate clinical, epidemiological and demographic data of patients with syphilis hospitalized at the Department of Dermatovenereology of the General Teaching Hospital in 2009 and to identify the groups at high risk of sexually transmitted diseases. The results were compared with the previous surveys carried out between 1999 and 2005 and also with the data of the National Registry of Venereal Diseases for 2008.
clinical manifestations
Clinical manifestations separate the disease into stages. Infection is initiated when T. pallidum penetrates dermal microabrasions or intact mucous membranes, typically resulting in a single chancre at the site of inoculation. Moderate regional lymphadenopathy is associated with the primary stage. The chancre usually becomes indurated and will progress to ulceration but typically is not purulent. Within hours of inoculation, and during the evolution of the primary stage, T. pallidum disseminates widely and organisms are deposited in a variety of tissues (2) .
Sore throat, muscle aches, malaise, and weight loss are examples of variable systemic symptoms of secondary syphilis. Generalized nontender lymphadenopathy occurs in up to 85% of cases. The most common manifestation of secondary syphilis is a disseminated mucocutaneous rash. Pale and discrete macular lesions appear initially on the trunk and proximal extremities; these are followed by lesions of various morphologies among patients. At diagnosis, the most common types of secondary syphilis lesions are maculopapular (in 50% to 70% of patients), papular (12%), macular (10%), and annular papular (6% to 14%) (6, 7, 8) . Rash is frequently found on the palms of the hands and soles of the feet and, in 4% to 11% of patients, T. pallidum infection of hair follicles results in alopecia of the scalp. There have also been infrequent reports of facial and body hair loss. Concurrent with the appearance of secondary lesions, about 10% of patients develop condylomata lata. These enlarged lesions, appearing in warm and moist areas including the perineum and anus, are highly infectious. Localized inflammation of the oral cavity, tongue, and genital mucous membranes can cause mucous patches (9, 10) ; infrequently, secondary syphilis can be accompanied by gastric and renal involvement and hepatitis (11) . Approximately 5% of individuals with secondary syphilis experience the early manifestations of neurosyphilis, including meningitis and ocular disease (6) . Latency is the period between healing of the clinical lesions and appearance of late manifestations, and it can last for many years. About 70% of untreated individuals will remain in this stage for the rest of their lives. Latency is characterized by positive serologic tests for specific antibodies without clinical signs or symptoms. Infectivity may occur intermittently due to the presence of treponemes in the bloodstream, and pregnant women with latent syphilis may infect the fetus in utero. The tertiary stage is also called late syphilis and is characterized by the presence of a small number of organisms and a high cellular immune reactivity against the organism. Signs of late syphilis can be recognized in approximately one-third of untreated individuals several months to years after being infected with treponemes. The microorganisms can invade the central nervous or cardiovascular systems and the skin (as well as other organs) and lead to damage due to host delayed-type hypersensitivity responses, which produce local inflammation and gummas in affected tissues.
Vaccine Development
Up until now, there is no usable vaccine available. There are several reasons why active syphilis vaccine development efforts should continue. These include prevention of HIV transmission, prevention of congenital syphilis in developing nations and, last but not least, prevention of the possible serious late sequelae of untreated syphilis.
In many studies, immunization with T. pallidum molecules (e.g. endoflagella, Gpd, TmpB, Tp92, TpN15, TpN47, TprF) was conducted and protection against infectious challenge was determined. Immunization stimulated the production of strongly reactive antibodies, some of which were shown to be opsonic. These immunization regimens, however, induced only partial protection, shown by attenuated development and rapid healing of lesions. This lack of complete protection in the face of high antibody titers suggests that the cellular immune response is critical to early clearance of T. pallidum. The requirement for cellular immunity in syphilis protection is supported by the fact that passive transfer of antibodies against T. pallidum, or against one of its lipid components, does not completely protect against infection. Additionally, the recombinant molecules used for immunization in many of these studies are likely not to be folded in native conformation; thus, antibodies that bind to conformational epitopes of native antigen may not be produced by immunization. Finally, the first targets of the immune response, outer membrane proteins, are very rare in T. pallidum. The identification of molecules found on T. pallidum's surface is likely to be essential for the development of an effective syphilis vaccine. It is hoped that their discovery and use in a multivalent vaccine will lead to the production of an effective vaccine for syphilis (2) .
epidemiology
Syphilis is distributed worldwide and is particularly problematic in developing countries, where it is a leading cause of genital ulcer disease. The World Health Organization estimates that 12 million new cases of syphilis occur each year (12) . Numbers and rates of infectious syphilis fell to their lowest levels in many European Union (EU) countries by the early 1990s (13, 14) , despite substantial increases in syphilis incidence in Russia (15, 16) . The decreases in western Europe were accompanied by marked reductions in the incidence of congenital syphilis and tertiary disease. By 1995, with the exception of Germany, fewer than 300 cases of infectious syphilis were recorded in any of the reporting EU countries. Since 1996, syphilis has again been on the increase in many northern and western EU countries (17) , in part driven by increases in cases among men who have sex with men, although more recent increases among heterosexual people have also been reported. An increase in new cases has also been noted in eastern Europe since the dissolution of the Soviet Union. The number of reported cases increased dramatically in the Russian Federation, from 7,911 in 1990 to 392,616 in 1997, with a similar phenomenon observed in other Eastern European countries (18) .
In the Czech Republic most cases of syphilis, total of 18,000 were diagnosed after the World War II during the mass screening of the population aged 15 to 40 years in 1951 (the "PN -venereal diseases action"). In the following years, the incidence of syphilis decreased considerably, the yearly incidence being in the range of hundreds. The incidence of syphilis has increased rapidly and substantially during the 1990s as a result of geopolitical and socioeconomic changes. The syphilis rate has risen eightfold, from 1.6 per 100,000 inhabitants in 1990 to 13.5 per 100,000 inhabitants in 2001 due to high proportion of syphilis cases among immigrants (Fig. 1 ). The proportion of immigrants rose from 5.4% in 1990 to 59% in 2001. Foreign patients came mainly from the Ukraine (42%), Moldavia (12.5%), the Russian Federation (8%), and Georgia (8%). From the epidemiologic point of view, the growth of the proportion of early syphilis (diagnosed within 2 years of infection) was significant in the 1990s. In 1990, the early form represented 24.4% of the total number of notified cases; in 1998 it had climbed to 65.6%. Since 2000, there has been an increase in the number of cases designated as late latent or of unknown duration, which represent 68.6% of the total number of reported cases in Our data on Prague's population basically correspond with the nationwide records. The reason for the rising syphilis notification rate has been credited to the political and socioeconomic changes in the Czech Republic in 1989 that have resulted in increased travel, economic migration, income differentials, dramatic increases in commercial sex and more open sex industry. From the epidemiologic point of view, the increase of the number of early infectious forms is significant. Their proportion was highest in 1996 (71.0%), declined to 35% in 2006 and rose again to 60.3% (4.9 cases per 100,000 inhabitants) in 2008. In our patients, the increased incidence of early forms is even more significant. Another trend is an increase in the number of infected men. While the proportion of hospitalized men and women was equal until 2006, in the last three years, we have recorded an increase among males, the male-female ratio being 3:1 in 2009. Compared to the previous study from 1999-2005, we have seen a significant increase of syphilis incidence in MSM (19, 23) . This trend corresponds to the situation in developed West European countries. In the developed European countries and USA, isolated outbreaks can be observed in homosexual communities, which are accounted for by the improved health condition of HIV-infected men, the highly active antiretroviral therapy and its better accessibility, the use of methamphetamine and Viagra and unprotected oral and anal intercourses (17, 24, 25) . These minor outbreaks were described for example in Dublin in 2001 through 2003, where 31% of homosexual men reported an unprotected oral intercourse and 15.9% unprotected anal intercourse (26) . Similar findings have been reported from Manchester, Bristol and London (27, 28) . In Denmark in 2004, homosexual men accounted for 78% of all newly reported cases, 37% of them being HIV-positive (29) . Similar data were reported from Belgium and Germany. In 2003, the syphilis incidence in Germany was 10 times higher among men than among women (75% of them being homosexuals and 50% HIV-positive). According to foreign studies, HIV/syphilis co-infection in homosexual men ranges from 20 to 73% (27, 30, 31) . The data on HIV/syphilis co-infection rates are lower among our patients, which is in concordance with relatively low HIV prevalence in the Czech Republic. The current reporting system does not capture data on HIV and syphilis co-infection; including these data into the reporting system would be important for initiating targeted prevention measures (32) . In heterosexual men, primary chancres most commonly occur on the penis, but 32 to 36% of homosexual men have primary chancres in other sites, including the rectum, anal canal, and oral cavity (33, 34) . The extragenital lesions among our patients were rare, suggesting that they were overlooked by the patients.
concluSionS
In the last four years, we have seen an increase in the number of syphilis cases among patients treated at the Department of Dermatovenereology in Prague, in line with nationwide trends. The age distribution did not change; majority of the patients were aged between 30 and 40. The proportion of foreigners also remained unchanged; they came mainly from the Slovak Republic and Ukraine. The increasing number of early symptomatic infections and infected homosexual men are the most significant epidemiologic findings, although heterosexual contact remained the most frequent route of syphilis transmission. This trend confirms the importance of contact-tracing, HIV and syphilis testing and the presumptive negative consequences of the abandonment of the serologic screening during the first hospitalization in the given year, which is no longer required by Czech legislation. Interventions delivered to whole populations, or groups in whom the risks of infection and onward transmission are very high, have the greatest potential effect. Effective action requires a multifaceted approach including better basic epidemiological and surveillance data supported by high quality evidence about effectiveness of individual interventions and programmes (1) . 
